Mobile

A study to evaluate reactogenicity and safety of two doses of GlaxoSmithKline (GSK) Biologicals’ oral live attenuated liquid human rotavirus (HRV) vaccine 444563, in healthy infants

Update Il y a 4 ans
Reference: EUCTR2012-001481-16

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To assess the reactogenicity of GSK Biologicals’ liquid HRV vaccine when compared to placebo in terms of grade “3” solicited adverse events (AEs).

Inclusion criteria

  • Healthy volunteers (Active immunisation of infants against gastroenteritis (GE) due to rotavirus (RV))

Links